Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is ...

The Indiana University School of Medicine has canceled its annual LGBTQ+ Health Care Conference, posting the change in a ...

Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is ...

Innovations in Patient Experience: A Modern Healthcare Event is a conference designed to showcase best practices for ...

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in ...

The National Basketball Players Association (NBPA) is stepping into the rapidly evolving world of digital health, biometric ...

A story in The Courier-Mail led to a swift and disproportionate response by the Queensland government. But then again, that ...

Health Care leaders are reacting to cuts to Medicaid reimbursement in Governor Dan McKee's proposed budget.Some health care ...

Medicenna Therapeutics Corp. ("Medicenna” or the "Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy co ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...